Literature DB >> 19604239

Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.

Ali Taher1, Khaled M Musallam, Fouad El Rassi, Lorena Duca, Adlette Inati, Suzane Koussa, Maria D Cappellini.   

Abstract

Non-transferrin-bound iron (NTBI) was evaluated as an index of iron overload in a cross-sectional randomised study in 74 non-transfused patients with thalassaemia intermedia (TI). Mean NTBI (2.92 +/- 3.43 micromol/l), serum ferritin (1023 +/- 780 ng/ml) and liver iron concentration (LIC; 9.0 +/- 7.4 mg Fe/g dry weight) were increased above reference-range levels. Significant positive correlations occurred between mean NTBI and LIC (Pearson correlation 0.36; P = 0.002) and serum ferritin (Pearson correlation 0.421; P < 0.0001); with higher levels observed in splenectomised patients. NTBI assessment has potential as a simple reliable approach to determining iron status in TI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604239     DOI: 10.1111/j.1365-2141.2009.07810.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.

Authors:  Yesim Aydinok; Patricia Evans; Chantal Y Manz; John B Porter
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 2.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.

Authors:  Louise de Swart; Jan C M Hendriks; Lisa N van der Vorm; Z Ioav Cabantchik; Patricia J Evans; Eldad A Hod; Gary M Brittenham; Yael Furman; Boguslaw Wojczyk; Mirian C H Janssen; John B Porter; Vera E J M Mattijssen; Bart J Biemond; Marius A MacKenzie; Raffaella Origa; Renzo Galanello; Robert C Hider; Dorine W Swinkels
Journal:  Haematologica       Date:  2015-09-18       Impact factor: 9.941

Review 4.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

5.  Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease.

Authors:  Ya-Li Zhou; Xin-Hua Zhang; Tie-Niu Liu; Li Wang; Xiao-Lin Yin
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

6.  Increased mitochondrial DNA deletions and copy number in transfusion-dependent thalassemia.

Authors:  Ashutosh Lal; Esteban Gomez; Cassandra Calloway
Journal:  JCI Insight       Date:  2016-08-04

7.  Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Authors:  Khaled M Musallam; Maria Domenica Cappellini; John C Wood; Irene Motta; Giovanna Graziadei; Hani Tamim; Ali T Taher
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

8.  Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.

Authors:  Tatsunori Goto; Katsuya Ikuta; Yoshihiro Inamoto; Sonoko Kamoshita; Emi Yokohata; Daisuke Koyama; Koichi Onodera; Aika Seto; Keisuke Watanabe; Nobuhiko Imahashi; Shokichi Tsukamoto; Yukiyasu Ozawa; Katsunori Sasaki; Masafumi Ito; Yutaka Kohgo; Koichi Miyamura
Journal:  Int J Hematol       Date:  2012-12-23       Impact factor: 2.490

Review 9.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

Review 10.  Iron dosing in kidney disease: inconsistency of evidence and clinical practice.

Authors:  Adam E Gaweda; Yelena Z Ginzburg; Yossi Chait; Michael J Germain; George R Aronoff; Eliezer Rachmilewitz
Journal:  Nephrol Dial Transplant       Date:  2014-05-12       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.